Response to SSRI antidepressants correlates with reduction in plasma HVA: Pilot study
- 15 October 1993
- journal article
- clinical trial
- Published by Elsevier in Biological Psychiatry
- Vol. 34 (8) , 569-571
- https://doi.org/10.1016/0006-3223(93)90202-o
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Homovanillic Acid Measurement in Clinical Research: A Review of MethodologySchizophrenia Bulletin, 1992
- Plasma free homovanillic acid (HVA) as a predictor of clinical response in acute psychosisBiological Psychiatry, 1991
- Ritanserin, a 5-HT2 receptor antagonist, activates midbrain dopamine neurons by blocking serotonergic inhibitionPsychopharmacology, 1989
- Longitudinal Measurement of Plasma Homovanillic Acid Levels in Schizophrenic PatientsArchives of General Psychiatry, 1986
- Interacting neurotransmitter systems. A non-experimental approach to the 5hiaa-hva correlation in human CSFJournal of Psychiatric Research, 1986
- Rapid and Simple Determination of Homovanillic Acid in Plasma Using High Performance Liquid Chromatography with Electrochemical DetectionActa Pharmacologica et Toxicologica, 1983
- Noradrenaline and 5‐hydroxytryptamine modulation of brain dopamine function: implications for the treatment of Parkinson's disease.British Journal of Clinical Pharmacology, 1983
- Brain contribution to the haloperidol-induced increase in plasma homovanillic acidEuropean Journal of Pharmacology, 1981
- Extrapyramidal side effects and increased serum prolactin following fluoxetine, a new antidepressantJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1979
- Serotonin-dopamine interactions in the nigrostriatal systemEuropean Journal of Pharmacology, 1979